MindBio Therapeutics Corp (CSE: MBIO) Reveals Scientific Paper in World-First Take-Home, LSD-Microdosing Clinical Trial in 80 Healthy Participants streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
MindBio clinical trial published in Peer Reviewed Paper Biological PsychiatryFirst of 8 significant publications on LSD-Microdosing from a Phase 1 clinical trialPhase 1 Clinical trial produced outstanding
Leading biotech/biopharm company MindBio lists on the Canadian Securities ExchangePsychedelic medicine fund, Negev Capital is a shareholderSuccessful completion of Phase 1 trial and two fully funded Phase
MindBio Therapeutics Corp (CSE:MBIO) Lists its Common Shares on the Canadian Securities Exchange streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Toronto, Ontario (Newsfile Corp. - Le 4 mai/May 2023) - The common shares of MindBio Therapeutics Corp. have been approved for listing on the CSE. Listing and disclosure documents will be available